Amarin Corp. Plc (AMRN)
14.78
-0.12
(-0.81%)
USD |
NASDAQ |
Jan 16, 16:00
14.78
0.00 (0.00%)
After-Hours: 20:00
Amarin EPS Diluted (Quarterly): -0.3702 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Trinity Biotech Plc | -0.274 |
| Jazz Pharmaceuticals Plc | 4.081 |
| DBV Technologies SA | -1.207 |
| Cellectis SA | 0.0058 |
| Biodexa Pharmaceuticals Plc | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.692M |
| Revenue (Quarterly) | 49.37M |
| Total Expenses (Quarterly) | 57.06M |
| Enterprise Value | 27.16M |
| Gross Profit Margin (Quarterly) | 42.97% |
| Profit Margin (Quarterly) | -15.58% |
| Earnings Yield | -28.18% |
| Normalized Earnings Yield | -20.79 |